Related references
Note: Only part of the references are listed.Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mouse Models
Yingjun Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Serotype I and II Feline Coronavirus Replication and Gene Expression Patterns of Feline Cells-Building a Better Understanding of Serotype I FIPV Biology
Sarah Cook et al.
VIRUSES-BASEL (2022)
Successful treatment of a South African cat with effusive feline infectious peritonitis with remdesivir
M. Bohm
JOURNAL OF THE SOUTH AFRICAN VETERINARY ASSOCIATION (2022)
Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care
Susan A. Olender et al.
CLINICAL INFECTIOUS DISEASES (2021)
The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite β-d-N4-hydroxycytidine in human plasma and saliva
Alieu Amara et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2021)
Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2
Wendy P. Painter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801
Angela Wahl et al.
NATURE (2021)
A retrospective study of clinical and laboratory features and treatment on cats highly suspected of feline infectious peritonitis in Wuhan, China
Yiya Yin et al.
SCIENTIFIC REPORTS (2021)
Curing Cats with Feline Infectious Peritonitis with an Oral Multi-Component Drug Containing GS-441524
Daniela Krentz et al.
VIRUSES-BASEL (2021)
Potential 3-chymotrypsin-like cysteine protease cleavage sites in the coronavirus polyproteins pp1a and pp1ab and their possible relevance to COVID-19 vaccine and drug development
Shaomin Yan et al.
FASEB JOURNAL (2021)
Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment
Jiashu Xie et al.
ACTA PHARMACEUTICA SINICA B (2021)
Unlicensed GS-441524-Like Antiviral Therapy Can Be Effective for at-Home Treatment of Feline Infectious Peritonitis
Sarah Jones et al.
ANIMALS (2021)
Analysis of the Potential for N4-Hydroxycytidine To Inhibit Mitochondrial Replication and Function
Zachary M. Sticher et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
FDA approves first peanut allergy drug
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2020)
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
Emmie de Wit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
A Tale of Two Viruses: The Distinct Spike Glycoproteins of Feline Coronaviruses
Javier A. Jaimes et al.
VIRUSES-BASEL (2020)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
Antiviral treatment using the adenosine nucleoside analogue GS-441524 in cats with clinically diagnosed neurological feline infectious peritonitis
Peter J. Dickinson et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
Lakshmanane Premkumar et al.
SCIENCE IMMUNOLOGY (2020)
3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice
Athri D. Rathnayake et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment
Victoria C. Yan et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
Wayne Vuong et al.
NATURE COMMUNICATIONS (2020)
High interindividual variability in plasma clopidogrel active metabolite concentrations in healthy cats is associated with sex and cytochrome P450 2C genetic polymorphism
Pamela M. Lee et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2019)
Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis
Niels C. Pedersen et al.
JOURNAL OF FELINE MEDICINE AND SURGERY (2019)
Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge
Michael K. Lo et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor
Krishani Dinah Perera et al.
VETERINARY MICROBIOLOGY (2019)
Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis
Niels C. Pedersen et al.
JOURNAL OF FELINE MEDICINE AND SURGERY (2018)
The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies
B. G. Murphy et al.
VETERINARY MICROBIOLOGY (2018)
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Maria L. Agostini et al.
MBIO (2018)
Improving Virus Taxonomy by Recontextualizing Sequence-Based Classification with Biologically Relevant Data: the Case of the &ITAlphacoronavirus 1&IT Species
Gary R. Whittaker et al.
MSPHERE (2018)
Characterizing replication kinetics and plaque production of type I feline infectious peritonitis virus in three feline cell lines
Amornrat O'Brien et al.
VIROLOGY (2018)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses
Michael K. Lo et al.
SCIENTIFIC REPORTS (2017)
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Travis K. Warren et al.
NATURE (2016)
Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor
Yunjeong Kim et al.
PLOS PATHOGENS (2016)
Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Clinicopathological findings and disease staging of feline infectious peritonitis: 51 cases from 2003 to 2009 in Taiwan
Hsien-Ying Tsai et al.
JOURNAL OF FELINE MEDICINE AND SURGERY (2011)
Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials
F. Fabrizi et al.
JOURNAL OF VIRAL HEPATITIS (2011)
The Combined Effect of Modern Highly Active Antiretroviral Therapy Regimens and Adherence on Mortality Over Time
Viviane D. Lima et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Significance of Coronavirus Mutants in Feces and Diseased Tissues of Cats Suffering from Feline Infectious Peritonitis
Niels C. Pedersen et al.
VIRUSES-BASEL (2009)
The Biochemistry of Drug Metabolism - An Introduction
Stefanie D. Krämer et al.
CHEMISTRY & BIODIVERSITY (2008)
Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients
RK Zeldin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Pharmacokinetic enhancement of protease inhibitors
EP Acosta
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2002)
Share Paper
